Two Sigma Investments, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $11.4 Million - $20 Million	-136,963 Reduced 87.04%	20,400 $2.97 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $4.67 Million - $6.06 Million	-42,430 Reduced 21.24%	157,363 $18.7 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $3.37 Million - $5.01 Million	33,771 Added 20.34%	199,793 $27.5 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $11.9 Million - $16.7 Million	120,165 Added 262.04%	166,022 $23.1 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $5.97 Million - $9.53 Million	-90,748 Reduced 66.43%	45,857 $4.45 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $3.8 Million - $5.44 Million	-59,270 Reduced 30.26%	136,605 $9.34 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $5.2 Million - $7.86 Million	-79,990 Reduced 29.0%	195,875 $16.8 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $11.2 Million - $14.7 Million	189,121 Added 218.02%	275,865 $17.9 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $51,666 - $132,203	1,781 Added 2.1%	86,744 $6.34 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $4.53 Million - $9.43 Million	-164,516 Reduced 65.94%	84,963 $2.89 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $7.74 Million - $10.9 Million	189,419 Added 315.38%	249,479 $13.6 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $1.66 Million - $2.19 Million	44,360 Added 282.55%	60,060 $2.51 Million
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $8.43 Million - $14.2 Million	-211,966 Reduced 93.1%	15,700 $688,000
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $7.86 Million - $12.1 Million	227,666 New	227,666 $11.7 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account